Sertraline Sandoz 50 mg

Sertraline Sandoz is a generic version of the selective serotonin reuptake inhibitor (SSRI) medication, commonly used for the treatment of depression and anxiety disorders. The Sandoz brand has deep historical roots in Switzerland, tracing back to the 19th century as a chemical company that eventually merged with Ciba-Geigy to form Novartis.

While the packaging shown reflects the brand's time as a division of the Swiss multinational Novartis, as of late 2023, Sandoz officially completed its spin-off to become an independent, publicly traded company. Sandoz operates a vast global supply chain, meaning their medications are manufactured in multiple international facilities located in regions such as Europe, North America, and Asia to meet local market regulations like those set by the Australian Therapeutic Goods Administration (TGA).